Skip to main content

Table 2 Demographics of the study population

From: Towards personalized fluid monitoring in haemodialysis patients: thoracic bioimpedance signal shows strong correlation with fluid changes, a cohort study

Demographic variables Study population (n = 66)
 Gender (male) 41 (62%)
 Height (cm) 166.3 ± 7.9
 BMI (kg/m2) 26.9 ± 4.5
 Age (years) 73 ± 12
 Smoking 17 (26%)
 Fistula 27 (41%)
 Hickmann Catheter 39 (59%)
 KT/V 1.41 ± 0.20
 Dialysis vintage (months) 49.2 ± 46.8
 Median UFV (mL) 1800 [1100–2400]
 Predialysis SBP/DBP (mmHg) 134.9 ± 22.1 / 64.3 ± 15.0
 Postdialysis SBP/DBP (mmHg) 129.5 ± 20.3 / 63.5 ± 12.6
Etiology of End-Stage Renal Disease
 Diabetic Kidney Disease 16 (24%)
 Non-diabetic Kidney Disease 53 (80%)
Comorbidities
 Cardiac Diseasea 39 (59%)
 Lung Disease (COPD) 7 (11%)
 Arterial Hypertension 47 (71%)
 Diabetes 29 (44%)
 Overweight 26 (39%)
 Obesity 15 (23%)
  1. aCardiac diseases identified within the study population: cardiomyopathy, systolic dysfunction, ischemic heart failure, decompensated heart failure, heart failure with reduced ejection fraction, coronary artery bypass grafting surgery, aortic valve stenosis and replacement, myocardial infarction, ventricular fibrillation and flutter, the presence of cardiac implantable electronic devices (e.g. pacemaker), atrial fibrillation, bundle branch block, left ventricular hypertrophy
  2. COPD chronic obstructive pulmonary disease; DBP diastolic blood pressure; SBP systolic blood pressure; UFV ultrafiltration volume